Pseudo-Kappa Light Chain Restricted Hematogones in Patients Receiving Daratumumab

Turk J Haematol. 2022 Feb 23;39(1):80-81. doi: 10.4274/tjh.galenos.2021.2021.0480. Epub 2021 Nov 18.
No abstract available

Keywords: Daratumumab; kappa; Hematogones; Cytometry; Artifactual.

MeSH terms

  • Antibodies, Monoclonal* / adverse effects
  • Flow Cytometry
  • Humans
  • Immunophenotyping
  • Multiple Myeloma* / diagnosis
  • Multiple Myeloma* / drug therapy

Substances

  • Antibodies, Monoclonal
  • daratumumab